Skip to content

Drug interactions

Amlodipine-olmesartan-hydrochlorothiazide + Lomitapide

Severity: Moderate

Amlodipine-olmesartan-hydrochlorothiazide and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Amlodipine is a weak CYP3A4 inhibitor and may raise lomitapide exposure, increasing the risk of hepatotoxicity and gastrointestinal adverse effects.

What this interaction means in plain words

Amlodipine-olmesartan-hydrochlorothiazide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Amlodipine-olmesartan-hydrochlorothiazide belongs to Cardiovascular; Lomitapide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Weak CYP3A4 inhibition by amlodipine reduces lomitapide metabolism.

What to do

Limit the lomitapide dose according to labeling for weak CYP3A4 inhibitors. Monitor liver enzymes and gastrointestinal tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amlodipine-olmesartan-hydrochlorothiazide and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Amlodipine-olmesartan-hydrochlorothiazide with Lomitapide?

MediHelp rates the interaction as moderate. Amlodipine-olmesartan-hydrochlorothiazide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Amlodipine is a weak CYP3A4 inhibitor and may raise lomitapide exposure, increasing the risk of hepatotoxicity and gastrointestinal adverse effects.

How serious is the interaction between Amlodipine-olmesartan-hydrochlorothiazide and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit the lomitapide dose according to labeling for weak CYP3A4 inhibitors. Monitor liver enzymes and gastrointestinal tolerability.

What other medicines interact with Amlodipine-olmesartan-hydrochlorothiazide?

MediHelp also lists interactions of Amlodipine-olmesartan-hydrochlorothiazide with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Amlodipine-olmesartan-hydrochlorothiazide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in